• ADMA Biologics will report third-quarter 2026 financial results on November 4, 2026, following the U.S. market close.
• Management will host a conference call and audio webcast on November 4 at 4:30 p.m. ET to discuss results and company updates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610280700PRIMZONEFULLFEED9854295) on October 28, 2026, and is solely responsible for the information contained therein.